Abbott Reports Strong Second Quarter Results – MarketWatch (press release)
Abbott Reports Strong Second Quarter ResultsMarketWatch (press release)Abbott is partnering on the development of a novel, next-generation antibody, daclizumab, which is currently in Phase 3 clinical trials for MS. Additionally, Abbott recently announc…
